Authors: Ballangrud, AM Yang, WH Charlton, DE McDevitt, MR Hamacher, KA Panageas, KS Ma, DS Bander, NH Scheinberg, DA Sgouros, G

Citation: Am. Ballangrud et al., Response of LNCaP spheroids after treatment with an alpha-particle emitter(Bi-213)-labeled anti-prostate-specific membrane antigen antibody (J591), CANCER RES, 61(5), 2001, pp. 2008-2014

Authors: McDevitt, MR Barendswaard, E Ma, D Lai, L Curcio, MJ Sgouros, G Ballangrud, AM Yang, WH Finn, RD Pellegrini, V Geerlings, MW Lee, M Brechbiel, MW Bander, NH Cordon-Cardo, C Scheinberg, DA

Citation: Mr. Mcdevitt et al., An alpha-particle emitting antibody ([Bi-213]J591) for radioimmunotherapy of prostate cancer, CANCER RES, 60(21), 2000, pp. 6095-6100

Authors: Ballangrud, AM Yang, WH Dnistrian, A Lampen, NM Sgouros, G

Citation: Am. Ballangrud et al., Growth and characterization of LNCaP prostate cancer cell spheroids, CLIN CANC R, 5(10), 1999, pp. 3171S-3176S

Authors: Sgouros, G Ballangrud, AM Jurcic, JG McDevitt, MR Humm, JL Erdi, YE Mehta, BM Finn, RD Larson, SM Scheinberg, DA

Citation: G. Sgouros et al., Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: Bi-213-HuM195 (anti-CD33) in patients with leukemia, J NUCL MED, 40(11), 1999, pp. 1935-1946